Three investment funds with holdings in Spanish drugmaker Grifols have teamed up to ask to fill a vacant seat on the company’s board, they said in a statement late on Thursday.
They said Grifols, which produces plasma-based medicines, had “an attractive growth profile” and its shares were undervalued and they wanted to make sure any takeover offer would include “a price that is fair for all shareholders”.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut: